Skip to main content

Early Detection

Advances research to determine the effectiveness and clinical impact – harms and benefits – of cancer early detection technologies and practices, including imaging and molecular biomarker approaches. Fosters technological development, statistical modeling, and dissemination of scientific findings to promote early cancer detection practices.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Resources

Cancer Data Access System (CDAS)

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	LeeVan, Elyse, M.D., M.P.H. elyse.leevan@nih.gov 240-276-7314	5E110	Program Officer \| Early Detection
	McCarty, Larae larae.mccarty@nih.gov 240-276-5777	5E322	Program Specialist \| Community Oncology and Prevention Trials Early Detection
	Miller, Eric, Ph.D. eric.miller2@nih.gov 240-276-5336	5E212	Program Officer \| Early Detection
	Ong, Mary Jane maryjane.ong@nih.gov 240-858-3296	5E120	Nurse Consultant \| Early Detection
	Pinsky, Paul, Ph.D. paul.pinsky@nih.gov 240-276-7014	5E108	Chief \| Early Detection
	Saxena, Neeraj, Ph.D. neeraj.saxena@nih.gov 240-276-6302	5E218	Program Officer \| Early Detection
	Zhu, Claire, Ph.D. claire.zhu@nih.gov 240-276-7013	5E106	Program Officer \| Early Detection

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Forsberg, Flemming	Thomas Jefferson University United States	Prostate Cancer Diagnosis by Multiparametric Ultrasound	5R01CA252311-05
Frazier, Anne Lindsay	Dana-Farber Cancer Inst United States	Assay Validation of a Circulating miRNA Test for Diagnosis and Monitoring of Malignant Germ Cell Tumors	5UH3CA240688-05	Nicholas Hodges, Ph.D.
Freedland, Stephen Jay	Cedars-Sinai Medical Center United States	Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes	3R01CA280081-03S1	Young Kim, Ph.D.
Friday, Bret E.B.	Essentia Institute Of Rural Health United States	Essentia Health Community Cancer Research Program - NCORP	3UG1CA189812-11S1	Vanessa A. White, M.P.H.
Furuta, Saori	Case Western Reserve University United States	Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift ofHER2+ breast cancer	5R01CA248304-05
Fuschiotti, Patrizia	University Of Pittsburgh At Pittsburgh United States	Develop IL13Ra1 for diagnosis of early-stage mycosis fungoides	5R21CA280445-02	Wendy Wang, Ph.D., M.Sc.
Garcia, Jose M.	Seattle Inst For Biomedical/Clinical Res United States	SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT)	5R01CA279220-02	Marjorie Perloff, M.D.
Geisler, Stefanie	Washington University United States	Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy	5R37CA267905-04	Asad Umar, D.V.M., Ph.D.
Germain, Doris A	Icahn School Of Medicine At Mount Sinai United States	Exploring ovarian-derived hormone STC1 as the mediator of the protective effect of breast feeding against breast cancer.	5R21CA270702-02	Marjorie Perloff, M.D.
Germain, Doris A	Icahn School Of Medicine At Mount Sinai United States	Investigating the efficacy of g-Tocotrienol for the prevention of post-partum breast cancer	1R01CA301372-01	Anda Vlad, M.D., Ph.D.
Ghamande, Sharad A.	Augusta University United States	Georgia CaRes	3UG1CA189851-11S1	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ghobrial, Irene M.	Dana-Farber Cancer Inst United States	Myeloma multidimensional precancer atlas	4U01CA294507-02	Nicholas Hodges, Ph.D.
Ghobrial, Irene M.	Dana-Farber Cancer Inst United States	Molecular prediction of myeloma in African Americans	5U01CA271492-04	Claire Zhu, Ph.D.
Ghosh, Jayashri	Temple Univ Of The Commonwealth United States	Development of blood-based methylation biomarkers for CRC risk prediction	5R01CA281948-03	Matthew Young, Ph.D.
Giles, Erin	University Of Michigan At Ann Arbor United States	Obesity, body fat distribution, and breast cancer risk: is visceral fat the culprit after menopause?	5R01CA269726-02	Marjorie Perloff, M.D.